Bim
Showing 1 - 25 of 76
Effectiveness of BIM in Reducing Disordered Eating Among Student Athletes, Effectiveness of BIM in Reducing Body Image Concerns
Recruiting
- Effectiveness of BIM in Reducing Disordered Eating Among Student Athletes
- +2 more
- Bodies in motion intervention program
-
Tucson, ArizonaThe university of Arizona
May 8, 2023
Cerebral Palsy Trial in Lyon (Early Intensive Bimanual Stimulation)
Recruiting
- Cerebral Palsy
- Early Intensive Bimanual Stimulation
-
Lyon, FranceCroix rouge française Centre Médico-Chirurgical de Réadaptation
Mar 10, 2022
Post Traumatic Stress Disorder Trial in Varces-Allières-et-Risset (Primary prevention programm)
Recruiting
- Post Traumatic Stress Disorder
- Primary prevention programm
-
Varces-Allières-et-Risset, France27 BIM
Apr 6, 2022
Non-small-cell Lung Cancer Trial in Shanghai (gefitinib combined with chemo, gefitinib combined with apatinib, gefitinib single
Unknown status
- Non-small-cell Lung Cancer
- gefitinib combined with chemotherapy
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital;
Jul 31, 2020
Stroke, Acute, Stroke, Subacute Trial in Yvoir (REAplan®, Dextrain Manipulandum®)
Not yet recruiting
- Stroke, Acute
- Stroke, Subacute
- REAplan®
- Dextrain Manipulandum®
-
Yvoir, Namur, Belgium
- +1 more
Mar 6, 2023
Monitoring T Cell Responses in Melanoma, Lung and Other Cancer
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +9 more
- Biospecimen Collection
- Electronic Health Record Review
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 4, 2023
Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen
Not yet recruiting
- Metastatic Endometrial Carcinoma
- +7 more
- Biopsy
- +5 more
- (no location specified)
Jan 18, 2023
Glaucoma, Open-Angle Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser
Completed
- Glaucoma
- Open-Angle Ocular Hypertension
- Bimatoprost SR
- +3 more
-
Dothan, Alabama
- +32 more
Feb 22, 2022
Pleural Malignant Mesothelioma Trial in Canada, United States (Anetumab Ravtansine, Laboratory Biomarker Analysis,
Active, not recruiting
- Pleural Malignant Mesothelioma
- Anetumab Ravtansine
- +3 more
-
Birmingham, Alabama
- +32 more
Dec 24, 2022
L-thyroxine Trial in Sharjah (Extra dose of L-thyroxine, 25 mcg during Ramadan)
Completed
- L-thyroxine
- Extra dose of L-thyroxine, 25 mcg during Ramadan
-
Sharjah, United Arab EmiratesFamily Promotion Centre, Endocrinology Clinic
Nov 16, 2023
Third Molar Trial (Monoject syringe)
Not yet recruiting
- Third Molar
- Monoject syringe
- (no location specified)
May 8, 2023
Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung
Active, not recruiting
- Advanced Lung Non-Squamous Non-Small Cell Carcinoma
- +5 more
-
Sacramento, California
- +17 more
Aug 2, 2022
Biomarkers for Invasive Mucormycosis
Not yet recruiting
- Mucorales Infection
- Mucormycosis
- Venous sample
- (no location specified)
May 31, 2022
High Grade Serous Carcinoma, Triple Negative Breast Cancer, Ovarian Cancer Trial (Olaparib tablet, Navitoclax)
Recruiting
- High Grade Serous Carcinoma
- +2 more
- Olaparib tablet
- Navitoclax
-
Toronto, Ontario, Canada
- +2 more
Nov 28, 2022
Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in New York, Nashville (Laboratory Biomarker Analysis,
Active, not recruiting
- Metastatic Uveal Melanoma
- Stage IV Uveal Melanoma AJCC v7
- Laboratory Biomarker Analysis
- Vorinostat
-
New York, New York
- +2 more
Jun 29, 2022
Aging, Physical Activity, Cognitive Function Trial in Calgary (Aerobic exercise)
Recruiting
- Aging
- +2 more
- Aerobic exercise
-
Calgary, Alberta, CanadaUniversity of Calgary
Nov 2, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +5 more
- Atezolizumab
- +3 more
-
Jacksonville, Florida
- +2 more
Oct 21, 2022
Takayasu Arteritis, Tocilizumab, Adalimumab Trial in Shanghai (Tocilizumab, Adalimumab)
Recruiting
- Takayasu Arteritis
- +3 more
- Tocilizumab
- Adalimumab
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Aug 7, 2021
Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia Trial in United States
Active, not recruiting
- Recurrent Acute Myeloid Leukemia
- +3 more
-
Tampa, Florida
- +5 more
Nov 18, 2022
Osteoarthritis, Knee Trial in Trondheim (Tourniquet)
Active, not recruiting
- Osteoarthritis, Knee
- Tourniquet
-
Trondheim, NorwayOrthopaedic department, Trondheim University Hospital
Apr 28, 2022
Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)
Not yet recruiting
- Lupus Nephritis
- Chronic Kidney Diseases
- Dapagliflozin 10mg Tab
- Standard maintenance therapy
-
Hong Kong, Hong KongQueen Mary Hospital
Nov 24, 2023